PofoliaShared via Pofolia

Archives of Pathology & Laboratory Medicine· 2017Q1· Guideline

Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists

James S. Lewis, Beth M. Beadle, Justin A. Bishop, Rebecca D. Chernock et al.

Short summary

High-risk HPV testing is recommended for all newly diagnosed oropharyngeal squamous cell carcinoma patients, using p16 immunohistochemistry with a 70% nuclear and cytoplasmic staining cutoff, but not routinely for other head and neck carcinomas.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Otorhinolaryngology

OtorhinolaryngologyMedicine